Finance Watch: Public Markets Open Back Up For Biopharma Offerings
AN2 Launches First US IPO In More Than A Month
Public Company Edition: An IPO and three big follow-on offerings hit the market but other public companies revealed plans to cut costs or reprioritize their R&D pipelines, signaling that uncertainty remains.
